Is it meaningful to pursue the safety of long-term lamivudine treatment in patients with chronic hepatitis B?

Gastroenterology

Volumn 126, Issue 7, 2004, Pages 1932-1933

  Lo, Gin Ho ^a   Lai, Kwok Hung ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN; LAMIVUDINE;

ANTIVIRAL THERAPY; CHRONIC HEPATITIS B; COST EFFECTIVENESS ANALYSIS; DECOMPENSATED LIVER CIRRHOSIS; DRUG SAFETY; HUMAN; LETTER; PRIORITY JOURNAL; SEROCONVERSION; TREATMENT DURATION; DRUG EFFICACY; HEPATITIS B; INFLAMMATION; LIVER DISEASE; LIVER NECROSIS; LONG TERM CARE; NONHUMAN; VIRUS MUTATION;

EID: 2942592485     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.04.041     Document Type: Letter

References (4)

1. Lok, A.S.F, Lai, C.L, Leung, N, Yao, G.B, Cui, Z.Y, Schiff, E.R, Dienstag, J.L, Heathcote, E.J, Little, N.R, Griffiths, D.A, Gardner, S.D, Castiglia, M, Long-term safety of lamivudine treatment in patients with chronic hepatitis B. Gastroenterology 125 (2003), 1714–1722.
2. Lai, C.L, Chien, R.N, Leung, N.W, Chang, T.T, Guan, R, Tai, D.I, Ng, K.Y, Wu, P.C, Dent, J.C, Barber, J, Stephenson, S.L, Gray, F, A one-year trial of lamivudine for chronic hepatitis B. N Engl J Med 339 (1998), 61–68.
3. Liaw, Y.F, Leung, N.W, Chang, T.T, Guan, R, Tai, D.I, Ng, K.Y, Chien, R.N, Dent, J, Roman, L, Edmundson, S, Lain, C.L, Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Gastroenterology 119 (2000), 172–180.
4. Leung, N.W.Y, Lai, C.L, Chang, T.T, Guan, R, Lee, C.M, Ng, K.Y, Lim, S.G, Wu, P.C, Dent, J.C, Edmundson, S, Condreay, L, Chien, R.N, Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy. Hepatology 33 (2001), 1527–1532.